17:42 JST, April 13, 2022
TOKYO (Jiji Press) — Abnormalities have been confirmed in some fetuses during animal tests for an oral COVID-19 drug developed by Shionogi & Co., which is pending regulatory approval, it has been learned.
Shionogi said data obtained from tests on animals suggest that the drug may not be recommended for use by pregnant women.
According to the company, teratogenic defects were confirmed in some fetuses during animal testing. The novel coronavirus pill has not been tested on expectant mothers during clinical trials.
While it is unknown what wording will be used to warn patients of the matter in the drug’s disclaimer, the wording will be decided by the government, with an official at Shionogi saying, “The phrases [on the warning label] will be decided during the drug review procedures, based on the data from animal testing.”
Shionogi has already reached a basic agreement with the government to supply the drug for 1 million people, based on the premise of the drug getting approved by the government.
The company is also planning to create by the end of fiscal 2022 a production system capable of manufacturing the drug for at least 10 million people every year.
"Society" POPULAR ARTICLE
-
Typhoon Nari Approaching Japan’s Kanto Region; Heavy Rain, Strong Wind Expected on Monday
-
Over 300 Earthquakes Rumble in Sea Off Japan’s Kagoshima Pref. Islands, Putting Residents on Alert
-
Typhoon Sepat Forms near Ogasawara Islands
-
M5.1 Earthquake Hits Japan’s Kagoshima Prefecture Islands
-
46-year-old Man Killed by Bear in Japan’s Nagano Prefecture; 2nd Man Sustained Minor Injuries
JN ACCESS RANKING
-
Japan’s Agriculture Ministry Starts Survey of Rice Farmers Across Japan on Production Outlook
-
5-Kilogram Bag of Rice Price Falls Below ¥4,000: 1st Time in 4 Months
-
Japan’s Core Inflation Hits 2-year High, Keeps Rate-Hike Bets Alive
-
Carmakers’ Anxiety Grows as U.S. Tariff Talks Stall;Japan Exporters May Have No Choice But to Raise Prices
-
Japan to Collaborate with 3 European Countries on Infrastructure Development; Will Work With Romania, Bulgaria, Czech Republic to Build Railroads, Energy Systems